Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

ALTG December 2018 News letter

2018 has been another outstanding year for the Australasian Lung Cancer Trials Group (ALTG). One of the significant highlights for 2018 has been the renewed funding arrangement from Cancer Australia for the next three years. Not only does this provide financial sustainability for the program over this time, it also recognises the enormous contribution the ALTG program offers lung cancer patients Australia wide

Clinical trials

The year began with recruiting participants across a diverse portfolio of clinical trials, with recruitment numbers tracking on or above schedule. We are working hard to offer new treatments to as many eligible lung cancer patients as possible. So far this year, the ALTG collaborative group recruited over 170 patients to our clinical trial portfolio and added at least one new trial to our extensive portfolio.


Education and events

One of the most important aspects of ALTG is connecting research outcomes, information and evidence to the scientific, healthcare professional and patient communities. 

Developing our next generation of researchers saw ALTG host our fourth annual preceptorship workshop. This event has become a must do for any new or emerging lung cancer consultant or researcher and in 2019, the preceptorship workshop will be held in October. For further details, visit our website here.


Our 3rd annual symposium was another fantastic and successful event with exceptional international and national speakers showcasing their knowledge and expertise to an eager audience. An inspirational tone for the event was set by Mr Chris Draft – Founder, President and CEO of the Chris Draft Family Foundation – who share his moving story about his wife, who sadly lost her battle to lung cancer in 2011.


New for 2018 was the addition of our speaking tours with the aim to increase ALTG presence in the local health care and patient communities. Positioned nicely after the World Lung Cancer Conference, the speaking tours were also an informal approach to shining a light on the progress to-date of research and the impact clinical trial outcomes have on the lung cancer space globally.

The ALTG membership continues to grow with over 740 members across Australia and New Zealand. We look forward to 2019 and building on the successes of this year to take ALTG’s scientific and educational endeavours to new heights and prominence on a global stage.

Thank you for all your support throughout the year and we wish you and your family a happy holiday.

Kind regards,

Nick Pavlakis
ALTG President